Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Fate Therapeutics, Inc. (FATE)

« Back to company index

FATE Chatter Timeline

Stock Ticker for FATE

Most Active Tweeters for FATE

UserTweets
@thejadedtrader 4
@1MinuteStock 4
@confcalltran 3
@Tickeron 3
@dhovekamp42 3

Recent Tweets for FATE

thejadedtrader @thejadedtrader
RT @jfais20: $FATE - Fate Therapeutics: Pioneer In iPSC Space Continues To Make Progress https://t.co/eWRMyX5t62
1:09pm
jfais20 @jfais20
$FATE - Fate Therapeutics: Pioneer In iPSC Space Continues To Make Progress https://t.co/eWRMyX5t62
10:09am
AmericanBanking @AmericanBanking
Fate Therapeutics $FATE Price Target Cut to $28.00 https://t.co/4e8mT793zj #stocks
9:09am
stockhoot @stockhoot
$FATE Piper Jaffray Maintains to Overweight : PT $28.00 https://t.co/T1ylWQF226
7:09am
SeekingAlpha @SeekingAlpha
$FATE - Fate Therapeutics: Pioneer In iPSC Space Continues To Make Progress https://t.co/IdH0UlTNkn
6:09am
ConsumerFeed @ConsumerFeed
Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/5uSsiu1CFj
September 15th 2019, 1:09pm
macondailynews @macondailynews
Fate Therapeutics $FATE Stock Price Down 5.1% https://t.co/2JMivP1YXT
September 14th 2019, 6:09pm
ZolmaxNews @ZolmaxNews
Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/o1pmfWBGD9
September 14th 2019, 12:09am
ZolmaxNews @ZolmaxNews
Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/PrIyozbmV4
September 13th 2019, 11:09pm
dailypoliticaln @dailypoliticaln
Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/kRtqojSIQ1
September 13th 2019, 11:09pm
WatchlistN @WatchlistN
Fate Therapeutics $FATE Shares Gap Down to $17.45 https://t.co/eekcufQlDV
September 13th 2019, 11:09pm
Tickeron @Tickeron
$FATE in Uptrend: 50-day Moving Average moved above 200-day Moving Average on October 10, 2017. View odds for this… https://t.co/z5rlwQrg9p
September 13th 2019, 10:09pm
ECMUS @ECMUS
RT @1stOncology: #FateTherapeutics Announces Pricing of Public Offering of Common Stock $FATE https://t.co/DA0FMZrvgs
September 13th 2019, 1:09pm
1stOncology @1stOncology
#FateTherapeutics Announces Pricing of Public Offering of Common Stock $FATE https://t.co/DA0FMZrvgs
September 13th 2019, 11:09am
1stOncology @1stOncology
#FateTherapeutics Announces Proposed Public Offering of Common Stock $FATE https://t.co/zcBSzYndXR
September 13th 2019, 11:09am
marketexclusive @marketexclusive
$FATE FATE THERAPEUTICS, INC. (NASDAQ:FATE) Files An 8-K Entry into a Material Definitive Agreement https://t.co/PEH0r2wRy5
September 13th 2019, 10:09am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $FATE for you: -2.47% https://t.co/QBxddcbBNG
September 13th 2019, 7:09am
1MinuteStock @1MinuteStock
Wondering about risks of $FATE? The 21-day volatility is 20.16% https://t.co/qWY2XKvF0U
September 13th 2019, 6:09am
confcalltran @confcalltran
Fate Therapeutics Announces Proposed Public Offering Of Common Stock https://t.co/Ljdr8UQBJp $FATE
September 13th 2019, 6:09am
confcalltran @confcalltran
FATE THERAPEUTICS INC just filed a prospectus, suggesting it plans to soon issue some securitie https://t.co/i72PlBlSox $FATE
September 13th 2019, 6:09am
registrarjourn @registrarjourn
Fate Therapeutics $FATE Trading Down 5.1% https://t.co/ViOK44kfrR
September 13th 2019, 12:09am
EnterpriseLeade @EnterpriseLeade
Fate Therapeutics $FATE Trading Down 5.1% https://t.co/a0qMPyNKq9
September 13th 2019, 12:09am
dispatchtribune @dispatchtribune
Fate Therapeutics $FATE Stock Price Down 5.1% https://t.co/78iUqHpiwK
September 12th 2019, 11:09pm
Tickeron @Tickeron
$FATE's 10-day Moving Average broke below its 50-day Moving Average on August 12, 2019. View odds for this and othe… https://t.co/kcsrIsGsXv
September 12th 2019, 7:09pm
FlynancialA @FlynancialA
$FATE . . . https://t.co/Z3Na7qFxfj
September 12th 2019, 6:09pm
BlindSpotFunds @BlindSpotFunds
@Dadbod4evah Its smart of $FATE to sell shrs now. In biotech, when the $ is available, take it ! To many CEOs, ov… https://t.co/H9kqyk0dtT
September 12th 2019, 9:09am
ToothFrank @ToothFrank
$FATE prices offering. 8.6M shares priced at $17.50/share
September 12th 2019, 8:09am
Briefingcom @Briefingcom
$FATE: Fate Therapeutics prices 8.6 mln shares of common stock at $17.50 per share https://t.co/hNNIhtDTov
September 12th 2019, 8:09am
LanderJesse @LanderJesse
RT @BioStocks: $FATE prices offering. 8.6M shares priced at $17.50/share.
September 12th 2019, 7:09am
BioStocks @BioStocks
$FATE prices offering. 8.6M shares priced at $17.50/share.
September 12th 2019, 6:09am
StockNewsWires @StockNewsWires
$FATE: Fate Therapeutics prices stock offering at $17.50: https://t.co/pa1BaiHJfi
September 12th 2019, 6:09am
MarketCurrents @MarketCurrents
$FATE - Fate Therapeutics prices stock offering at $17.50 https://t.co/j4SC0bZhFW
September 12th 2019, 5:09am
dhovekamp42 @dhovekamp42
RT @_B_I_O_T_E_C_H_: $Fate Therapeutics Prices Underwritten Public Offering Of 8.6 Mln Shares At $17.50/Shr
September 12th 2019, 4:09am
_B_I_O_T_E_C_H_ @_B_I_O_T_E_C_H_
$Fate Therapeutics Prices Underwritten Public Offering Of 8.6 Mln Shares At $17.50/Shr
September 12th 2019, 3:09am
2ndry_filings @2ndry_filings
$FATE - Overnight - No Shares Disclosed - Jefferies, Citi • Commentary on if you should indicate for $FATE or if yo… https://t.co/WLwU5efXlI
September 12th 2019, 1:09am
StockTexts @StockTexts
$FATE Fate Therapeutics Announces Pricing of Public Offering of Common Stock Nasdaq:FATE https://t.co/1onnEL0p3A
September 12th 2019, 1:09am
tstamm7002 @tstamm7002
$FATE offering ahead of some key clinical disclosures this fall. timing is suspect
September 11th 2019, 10:09pm
Tickeron @Tickeron
$FATE's Aroon indicator reaches into Uptrend on September 9, 2019. View odds for this and other indicators:… https://t.co/oqs3Qjy9Y8
September 11th 2019, 7:09pm
thejadedtrader @thejadedtrader
$EDIT and $FATE differentiates from MD Anderson by using iPSC vs chord blood derived NK cells. With the correct ed… https://t.co/V3yxtc0kM0
September 11th 2019, 6:09pm
thejadedtrader @thejadedtrader
CAR-NK vs CAR-T $EDIT $FATE https://t.co/hT5jpWE2vo
September 11th 2019, 6:09pm
thejadedtrader @thejadedtrader
$FATE https://t.co/UcjHk2Lani
September 11th 2019, 6:09pm
1MinuteStock @1MinuteStock
Not sure what to do with $FATE? Explore our #fundamental pros and cons. https://t.co/jHpjDms2ik
September 11th 2019, 6:09pm
Briefingcom @Briefingcom
$FATE: Fate Therapeutics commences public offering of common stock; amount of shares not disclosed https://t.co/iXTHLVYkKB
September 11th 2019, 6:09pm
dhovekamp42 @dhovekamp42
RT @TheTradeXchange: $FATE: Announces Proposed Public Offering of Common Stock.. Jefferies and Citi bookmanagers
September 11th 2019, 5:09pm
dhovekamp42 @dhovekamp42
RT @Stock_News_Now: $FATE: New SEC Filing for FATE: Form 424B5 (No. 0001193125-19-242947): https://t.co/fL8ENHd99O
September 11th 2019, 5:09pm
1MinuteStock @1MinuteStock
Do you know that #Book Value for $FATE is $1.95 https://t.co/hUBxlkxpcj
September 11th 2019, 5:09pm
gulfgator33 @gulfgator33
$FATE Ha, can't say I'm surprised, hopefully there will be strong demand. Such is the world of bio-tech
September 11th 2019, 4:09pm
Stock_News_Now @Stock_News_Now
$FATE: New SEC Filing for FATE: Form 424B5 (No. 0001193125-19-242947): https://t.co/fL8ENHd99O
September 11th 2019, 4:09pm
confcalltran @confcalltran
FATE THERAPEUTICS INC just filed a prospectus, suggesting it plans to soon issue some securitie https://t.co/rOgib7lVif $FATE
September 11th 2019, 4:09pm
soloalam1 @soloalam1
RT @MarketCurrents: $FATE - Fate Therapeutics launches stock offering https://t.co/O3pvj6PEWw
September 11th 2019, 4:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.